Medico Intercontinental Limited
- Company typePublic
- Founded1984
- HeadquartersAhmedabad, India
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Medico Intercontinental Limited firmographics
Firmographics- Name
- Medico Intercontinental Limited
- Legal name
- Medico Intercontinental Limited
- Website
- https://medicointercontinental.com
- Company type
- Public
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Medico Intercontinental Limited industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
- akta.pro secondary industries
- Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA), Medical & Clinical Nutrition Beverage Production (Oral Nutritional Supplements) (AFAFAFAJ)
Keywords
Where Medico Intercontinental Limited is headquartered
LocationHeadquarters
- HQ city
- Ahmedabad
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Medico Intercontinental Limited business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Pharmaceutical Product Sales: Sale of manufactured pharmaceutical products across multiple therapeutic categories including Gastro, Uro, Nutrition, Cosmetology, Health Devices, and Hospital segments. Products are distributed through franchise networks and direct B2B sales to healthcare providers.
- Third Party / Contract Manufacturing: The company offers third-party manufacturing services to other pharmaceutical companies, providing manufacturing capacity and expertise to partners seeking production capabilities.
- Franchise Network Revenue: Revenue generated through franchise partnerships for product distribution across geographic regions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Pharmaceutical products sold through franchise network |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
Medico Intercontinental Limited product offering
Product offeringCore offering
Medico Intercontinental Limited manufactures and distributes a comprehensive portfolio of pharmaceutical formulations across multiple therapeutic categories (Gastro, Uro, Nutrition, Cosmetology, Health Devices, Hospital, Psychiatric, Derma, Eye Care) in multiple formats including tablets, capsules, soft gelatin capsules, injectables, ointments, liquids, dry syrups, suspensions, infusions, soaps, dental, and Ayurvedic preparations. The company also operates a specialized Vitamin D3 (Cholecalciferol) brand called Calborn, a MEDICO FTF consumer product line (hand sanitizers, masks, cleaners), and offers third-party/contract manufacturing services to other pharmaceutical companies. Products are sold through direct B2B sales to healthcare providers and a franchise distribution network.
Product overview
Medico Intercontinental Limited is a biopharmaceutical company that manufactures and distributes a comprehensive portfolio of pharmaceutical products across multiple therapeutic categories. The company's offerings are organized into distinct product lines: General Range (the largest portfolio with tablets, capsules, soft gelatines, injectables, liquids, ointments, powders, dental, ayurvedics, soaps, nutritional, infusion, and dry syrups), Vitamin D3 (cholecalciferol in pharmaceutical, nutraceutical, food, and feed grades), MEDICO FTF (first-to-market consumer health products), Derma Range (dermatological formulations in tablets, ointments, injectables, soaps), Psychiatric Range (neuropsychiatric medications), Eye Drops (ophthalmic preparations), and Upcoming Products (pipeline formulations). The company serves global markets through research-based biopharmaceutical partnerships, focusing on making novel therapies accessible and affordable worldwide.
Differentiator
Problem solved
Functional benefit
Brands
- Calborn: Vitamin D3 brand specializing in manufacturing Vitamin D3 in various grades, strengths, and forms including pharmaceutical, nutraceutical, food, and feed grade for multiple applications.
Products and services
- Calborn Vitamin D3 (Cholecalciferol) Branded Vitamin D3 (Cholecalciferol) line offered in pharmaceutical, nutraceutical, food, and feed grades in oil and powder forms, for applications including bone health, immunity, calcium absorption, tablets, capsules, syrups, soft gel, sachets, shots, injections, dietary supplements, beverages, dairy products, cereals, juices, and animal nutrition.
- General Range Tablets Over 130 tablet formulations covering antibiotics (FIMI, CEFUACT, MOXIPLUS), analgesics (ACIFACT, DOLOFACT), gastrointestinal (RABICARE, OMCARE), psychiatric (GABAFACT, FLOCITOP), and other therapeutic categories for healthcare provider distribution.
- Soft Gelatin Capsules Soft gelatin capsule formulations including ALFACARE M CAP, CALCEETROL, CALCEE-K2, EFACT 400, FOLICARE PLUS, ISOFACT, LYCOFACT, MYOFACT-L, OME 369, OXYVITAL, PRIME 4G, PRIME 9G, PREGOFACT, Q CARE FORTE, and ZED-Q sold to healthcare providers.
- Hard Capsules Hard capsule formulations including BROFACT-A (acebrophylline), CINFAST-R, ESOMED-L, GLUFACT (probiotics), IT-CARE (itraconazole), IROVIT CAP, LYMARIN CAP, MOXIPLUS, OMCARE, OXYVIT, PCARE, and PREGAFACT.
- Dental Products Oral care products including ORODENT gum paint, OROFACT mouthwash, OROFACT toothpaste, and OROFACT mouth ulcer gel for dental and oral health applications.
- Ointments and Creams (General) Topical formulations including CLOFACT, CLOFACT-S, CLOFACT-PLUS, CLOFACT GM, E-FACT products, FUSIDEC, KTZ shampoo, KTMED, LULISER, MUFACT, M-FACT, RELIDERM, RELIDINE-S, RELIFEN PLUS, SERTAMED, TERBACT, and combination formulations.
- Powders and Sprays Powder and spray formulations including ARGIFACT (L-arginine), ARGIFACT DHA, CLIANCIACT powder, EMTRAL salts, GLUFACT probiotic sachets, GET D3, PROCARE powder, RELIEVE CZ, RACIMAX, and VOLIREX spray.
- Liquids and Syrups Liquid preparations including BECOFACT-L syrup, BROFACT formulations, COLD RELIEVE syrup, CODINEX, CYPROFACT, FERROFACT, GET-D3 oral solution, IROFACT SF, IROVIT, LYMARIN syrup, LIVFACT-XL, MEDISER, MEDIZINC, MKOOL, OMCARE gel, OXYVIT, OXYFACT-M, PROCARE tonic, RELIDRYL, SURFACT, TUXOL, and ZEDCARE.
- Ayurvedic Formulations Ayurvedic preparations including FEMYACT uterine tonic, LIVOFACT liver tonic, RELIEVE cough syrup, RELIFEN P oil, ULTRATONE, and ZYMIX enzyme tonic.
- Injectables Parenteral products including ALFACARE PLUS, AMIFACT (amikacin), ARSUFACT (artesunate), ARTIFACT (arteether), CEFTACT, DECOFACT (nandrolone), ESOFACT, FLOCITAM INJ, LEVOSIDE INJ, MEDICORT, MEDOL, MEROFACT, MOXIPLUS CV, ONCARE, PCARE IV, PIXIACT, RELIFEN-AQ, RANIFACT-O, RABICARE INJ, SAFECARE series, SAFEZONE-S, and TAZOMED-P.
- Dry Syrups, Suspensions and Drops Pediatric and oral suspension formulations including ALBECTIN SUS, ACIFACT P SUS, BECOFACT drops, COLIFACT, DEFZACT SUS, FIMI dry syrup, IMMUMED SUS, KUFFACT-P, LEVEREST syrups, MEFACT P, MOXI PLUS CV DS, MOXIFORTE, ONCARE solution, OFCARE formulations, PRODOM dry syrups, RELIBEN, and ZIFT suspensions.
- Infusion Products IV infusion products including PARACT IV (paracetamol), LINZO INF (linezolid), and MANIFACT I.V (mannitol/glycerin).
- Medicated Soap Products Medicated soaps including PERMACT (permethrin/neem), EFACT (aloe vera/vit E), OROFACT (chlorhexidine), and KTZ (ketoconazole).
- Nutritional Products Nutritional supplements including CAMBOGIA (garcinia weight loss) and WHEY PROTEIN POWDER.
- Eye Drops Ophthalmic formulations including CIPACT, I-NORM nasal drops, LUBRIACT, M CLOR-DX, M CLOR-CB, MCM tear drops, MDAS, MDAS-DX, MEDIFLOX, MEDIFLOX KT, OFCARE eye drops, OLOFACT, and TIMOCARE.
- Psychiatric Range Formulations Psychiatric and neurological medications including AMISURE, DIVACT-ER, EPSOMED, FLOCITAM, FLOCITOP, FLOCLID, FLOHEX, FLOBAM, FLONA, FLOPAM, FLORANZ, FLORES, FLOSERT, FLOTIN, FLOZINE, FLUXIP, GABAFACT, LEVOSIDE, MEDITRYP, OXCAR SR, PROFLO, PREGAFACT, QUP, VALFACT CR, XETA, XZOLAM, and ZOLCARE.
- Derma Range Tablets Dermatological tablet formulations including ALFAGLOW (glutathione complex), CLAMED-250, DOXYCARE-L, DEFZACT, FEXOFACT-120, HIZEN, KTZ-200, LEVEREST-10, TERBACT, and ZIFTMED (azithromycin).
- Derma Range Ointments and Creams Dermatological topical products including ALFAGLOW, CLIANCIACT (clindamycin/nicotinamide), CLOFACT-S, CLOFACT-PLUS, CALAMED lotion, E-FACT products, FUSIDEC, IT-CARE, KTMED, KTZ shampoo, LULISER, M-FACT, M-FACT HT, MUFACT, OM-TC, RELIDINE-S, SERTAMED, TACMED, and TERBACT variants.
- MEDICO FTF (First-to-Find) Consumer Products First-to-market consumer health products including Antiseptic Liquid, Multi Purpose Cleaner, Hand Sanitizer (gel and liquid in various sizes), Hand Wash (lemon, neem/tulsi), Immunity Booster tablets, and N95 Face Masks.
- Third-Party / Contract Manufacturing Services Contract manufacturing services offered to other pharmaceutical companies across multiple dosage forms including tablets, capsules, soft gelatin capsules, injectables, ointments, liquids, dry syrups, suspensions, infusions, and Ayurvedic formulations.
- Pharmaceutical Franchise Distribution Network Franchise partner program for distribution of Medico pharmaceutical products across geographic regions in India, with dedicated franchise contact channels.
Companies that use Medico Intercontinental Limited
Customer profileSegments4 records
Ideal customer profiles4 records
Medico Intercontinental Limited technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Medico Intercontinental Limited partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Research-based Biopharmaceutical CompaniescoreMedico Intercontinental provides a platform to all research-based biopharmaceutical companies, enabling them to reach their novel and innovative therapies to every part of the globe. The company is open for high-value partnerships with companies and organizations whose strength compliments and augments their own.
- Franchise PartnerscoreThe company distributes pharmaceutical products through franchise partners across geographic regions. Franchise inquiries are handled through dedicated contact channels (+91-9898508903).
- Third-party Manufacturing ClientsminorThe company offers third-party manufacturing services to other pharmaceutical companies seeking manufacturing capacity. Contact: +91-9898508911.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Medico Intercontinental Limited competitors and assessment
Company assessmentBroad incumbents
- Mankind Pharma Limited: Larger Indian pharma with strong branded generics and OTC presence across gastro, derma, and vitamins. Comparable branded-generic orientation and therapeutic overlap, but operates at materially larger scale with deeper distribution.
- Torrent Pharmaceuticals Limited: Larger established Indian pharma with branded generics across therapeutic areas overlapping with Medico's portfolio. Comparable therapeutic categories but at significantly larger scale with deeper field force.
Direct peers
- Ipca Laboratories Limited: Indian pharmaceutical manufacturer producing formulations across multiple dosage forms and therapeutic categories, with similar export and domestic B2B orientation. Comparable in portfolio breadth and manufacturing capability.
- Alembic Pharmaceuticals Limited: Indian pharma manufacturer with branded generics across multiple therapeutic areas plus API manufacturing. Similar size class, listed entity, and diversified dosage form production.
- Eris Lifesciences Limited: Indian specialty pharma focused on chronic therapy categories (cardio, diabetes, CNS, derma) with a similar field force and franchise distribution approach. Comparable therapeutic focus on chronic and specialty segments.
- Ajanta Pharma Limited: Indian specialty pharma with a comparable branded generics portfolio across multiple therapeutic areas (cardio, dermatology, ophthalmology) and similar B2B + franchise distribution model. Similar size class and product breadth make it the closest direct comparable.
- Unichem Laboratories Limited: Indian generics manufacturer with branded formulations across multiple therapeutic segments including gastro, cardio, and dermatology. Comparable formulation-led, multi-category approach.
- Marksans Pharma Limited: Smaller Indian pharma with formulation manufacturing across multiple dosage forms and OTC presence. Comparable size, similar generic formulation focus, and US export orientation.
- Caplin Point Laboratories Limited: Indian pharma with semi-regulated and regulated market focus, plus franchise distribution model for domestic business. Similar therapeutic breadth and franchise-heavy GTM.
- JB Chemicals & Pharmaceuticals Limited: Indian pharma with a diverse portfolio across multiple therapeutic categories including derma, gastro, and vitamins. Similar mid-tier positioning with both domestic and export sales.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key highlights5 records
Customer concentration
Medico Intercontinental Limited financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medico Intercontinental Limited leadership team
Management profileNumber of profiles
Profiles6 records
Medico Intercontinental Limited subsidiaries and ownership
Company hierarchySubsidiaries5 records
Medico Intercontinental Limited funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medico Intercontinental Limited M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medico Intercontinental Limited
What does Medico Intercontinental Limited do?
Medico Intercontinental Limited manufactures and distributes a comprehensive portfolio of pharmaceutical formulations across multiple therapeutic categories (Gastro, Uro, Nutrition, Cosmetology, Health Devices, Hospital, Psychiatric, Derma, Eye Care) in multiple formats including tablets, capsules, soft gelatin capsules, injectables, ointments, liquids, dry syrups, suspensions, infusions, soaps, dental, and Ayurvedic preparations. The company also operates a specialized Vitamin D3 (Cholecalciferol) brand called Calborn, a MEDICO FTF consumer product line (hand sanitizers, masks, cleaners), and offers third-party/contract manufacturing services to other pharmaceutical companies. Products are sold through direct B2B sales to healthcare providers and a franchise distribution network.
Is Medico Intercontinental Limited a public or private company?
Medico Intercontinental Limited is a public company. It is classified as public and is currently operating.
When was Medico Intercontinental Limited founded?
Medico Intercontinental Limited was founded in 1984. It employs 11 to 50 people.
Where is Medico Intercontinental Limited based?
Medico Intercontinental Limited is headquartered in Ahmedabad, India, in the Asia region.
How does Medico Intercontinental Limited make money?
Three revenue lines are on record. Pharmaceutical Product Sales are the primary driver. The others are third Party / Contract Manufacturing and franchise Network Revenue.
Who are Medico Intercontinental Limited's main competitors?
Broad incumbents on record are Mankind Pharma Limited and Torrent Pharmaceuticals Limited. Direct peers are Ipca Laboratories Limited, Alembic Pharmaceuticals Limited, Eris Lifesciences Limited, Ajanta Pharma Limited, Unichem Laboratories Limited, Marksans Pharma Limited, Caplin Point Laboratories Limited and JB Chemicals & Pharmaceuticals Limited.
Does Medico Intercontinental Limited have an API?
No public API is recorded for Medico Intercontinental Limited.
What industry is Medico Intercontinental Limited in?
Medico Intercontinental Limited's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of IMALAIAA, Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules). Its NAICS code is 3254 and its SIC code is 2834.